A Study to Investigate Intravenous Tocilizumab in Participants With Moderate to Severe COVID-19 Pneumonia
Clinical trial NCT04363736 · COMPLETED
Trial details
- NCT number
- NCT04363736
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-05
- Primary completion
- 2020-08-12
- Enrollment
- 97
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.